| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 36.6315 | 1 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.5028 | 43 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.1619 | 46 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.3853 | 38 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.3859 | 19 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.1384 | 23 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.8837 | 45 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 54.1634 | 58 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.0614 | 22 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.5648 | 43 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.3705 | 43 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.1082 | 18 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.4931 | 43 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.3685 | 34 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 39.521 | 5 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.2303 | 14 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.2692 | 33 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.3522 | 15 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 39.0416 | 4 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 37.7716 | 2 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.0152 | 17 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.7416 | 31 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 38.8801 | 4 |